Search

Your search keyword '"Therapeutic decision making"' showing total 6 results
Start Over Descriptor "Therapeutic decision making" Journal journal of the american college of cardiology
6 results on '"Therapeutic decision making"'

1. PCSK9 Inhibition for Therapeutic Decision-Making

Author

William E. Boden and William S. Weintraub

Subjects
Actuarial science, business.industry, Cost effectiveness, PCSK9, MEDLINE, Medicine, Economic analysis, Therapeutic decision making, Cardiology and Cardiovascular Medicine, business, Value (mathematics), Alirocumab
Published
2020

2. Reply

Author

Philipp E. Bartko, Georg Spinka, Georg Goliasch, Noemi Pavo, and Martin Hülsmann

Subjects
Mitral regurgitation, Potential impact, medicine.medical_specialty, business.industry, MEDLINE, Therapeutic decision making, 030204 cardiovascular system & hematology, Integrated approach, 03 medical and health sciences, 0302 clinical medicine, medicine.anatomical_structure, Mitral valve, Mitral valve annuloplasty, Medicine, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, Intensive care medicine
Abstract

Drs. Tan and Nunes carefully interpret the results of this study [(1)][1] toward potential impact on subsequent therapeutic decision making. As pointed out correctly, the contemporary pathophysiologic concept of secondary mitral regurgitation (sMR) identifies 2 key mechanisms, each of which might

Published
2019

3. THE PARADOX OF CHOICE: THERAPEUTIC DECISION MAKING WITH COMPLEX PULMONARY EMBOLI

Author

Erin Mancl, Jeremiah Haines, Bruce E. Lewis, Yevgeniy Brailovsky, Jason Frazier, Stephen A. Morris, Dalila Masic, Demetrios Doukas, Verghese Mathew, Kateria Porcaro, Amir Darki, Anthony Perez-Tamayo, and Jawed Fareed

Subjects
medicine.medical_specialty, business.industry, Therapeutic decision making, medicine.disease, Pulmonary embolism, Dilated right ventricle, Internal medicine, Ischemic stroke, medicine, Patent foramen ovale, Cardiology, Cardiology and Cardiovascular Medicine, Acute dyspnea, business
Abstract

Acute pulmonary embolism (PE) in the setting of a Patent Foramen Ovale (PFO) and clot-in-transit across the PFO poses a therapeutic dilemma. 64 year old male presented with acute dyspnea 3 weeks after ischemic stroke. CT PE-protocol revealed dilated right ventricle (RV) and proximal bilateral

Published
2019

4. ASSESSMENT OF THROMBOGENICITY AND ANTITHROMBOTIC DRUG RESPONSE AT THE BEDSIDE IN PATIENTS PRESENTING WITH ISCHEMIC STROKE, TIA OR INTRACRANIAL HEMORRHAGE

Author

Christopher J. McLeod, Trish Brannan, Eli Cohen, Gabriel Raviv, Adina A. Muresan, John W Cochran, Carlos G. Lopez-Espina, Paul A. Gurbel, Udaya S. Tantry, and Kevin P. Bliden

Subjects
medicine.medical_specialty, business.industry, Thrombogenicity, Therapeutic decision making, medicine.disease, Anesthesia, Ischemic stroke, Antithrombotic, Emergency medicine, Drug response, Medicine, In patient, Observational study, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, Stroke
Abstract

Background: Early assessment of antithrombotic effects may be important for therapeutic decision making in patients presenting with stroke and TIA. Methods: In this prospective observational study, 80 patients presenting with symptoms suggestive of stroke and 45 patients with stroke-like symptoms

Published
2017

5. USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKING

Author

Samir Kapadia, Anthony C. DeFranco, Timothy Henry, Sandra Weiss, Samantha Sartori, Stuart J. Pocock, Roxana Mehran, Melissa Aquino, Annapoorna Kini, Stuart Keller, Brian A. Baker, Jaya Chandrasekhar, William S. Weintraub, Usman Baber, J. Muhlestein, Catalin Toma, Mark B. Effron, Olga Salianski, Sunil V. Rao, and Kanhaiya L. Poddar

Subjects
medicine.medical_specialty, Acute coronary syndrome, Prasugrel, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, Therapeutic decision making, Platelet inhibition, Clopidogrel, medicine.disease, Internal medicine, Conventional PCI, Cardiology, Medicine, In patient, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract

The determinants of clinical decision-making for potent platelet inhibition with prasugrel versus clopidogrel in real-world patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) remain poorly characterized. The purpose of this study was to identify factors

Published
2016

6. Cardiac sources of embolism: value of two- and three-dimensional echocardiography in therapeutic decision-making

Author

A Deicker, Hans-Christoph Diener, Silvana Müller, Thomas Bartel, and Raimund Erbel

Subjects
medicine.medical_specialty, Embolism, business.industry, Internal medicine, medicine, Cardiology, Three dimensional echocardiography, Radiology, Therapeutic decision making, medicine.disease, business, Cardiology and Cardiovascular Medicine, Value (mathematics)
Published
1998
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results